Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Minority Interest (2025 - 2026)

Champions Oncology has reported Minority Interest over the past 5 years, most recently at $95000.0 for Q1 2026.

  • Quarterly results put Minority Interest at $95000.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Jan 2026 was $95000.0 (changed N/A YoY), and the annual figure for FY2013 was $16.9 million, up 106.91%.
  • Minority Interest for Q1 2026 was $95000.0 at Champions Oncology, up from $61000.0 in the prior quarter.
  • Over the last five years, Minority Interest for CSBR hit a ceiling of $95000.0 in Q1 2026 and a floor of $30000.0 in Q3 2025.